We have devised a two-step procedure by which multiple copies of a heterologous gene can be consecutively integrated into the Bacillus subtilis 168 chromosome without the simultaneous integration of markers (antibiotic resistance). The procedure employs the high level of transformability of B. subtilis 168 strains and makes use of the observation that thymine-auxotrophic mutants of B. subtilis are resistant to the folic acid antagonist trimethoprim (Tmp r ), whereas thymine prototrophs are sensitive. First, a thymine-auxotrophic B. subtilis mutant is transformed to prototrophy by integration of a thymidylate synthetase-encoding gene at the desired chromosomal locus. In a second step, the mutant strain is transformed with a DNA fragment carrying the heterologous gene and Tmp r colonies are selected. Approximately 5% of these appear to be thymine auxotrophic and contain a single copy of the heterologous gene at the chromosomal locus previously carrying the thymidylate synthetase-encoding gene. Repetition of the procedure at different locations on the bacterial chromosome allows the isolation of strains carrying multiple copies of the heterologous gene. The method was used to construct B. subtilis strains carrying one, two, and three copies of the Bacillus stearothermophilus branching enzyme gene (glgB) in their genomes.
Until now, the use of genetically engineered bacteria for the high-level expression of heterologous genes has depended almost entirely on the presence of antibiotic resistance genes for the maintenance of segregationally unstable plasmids carrying the gene of interest. The presence of these antibiotic resistance genes in genetically engineered bacteria has retarded the introduction of these highly potent microorganisms as production organisms for clinically and industrially important enzymes. A more feasible approach for the stabilization of heterologous genes in an industrially important bacterium would be integration of the gene of interest into its genome. So far, integration of multiple copies of a heterologous gene into bacterial genomes, required for high-level expression, has only been achieved by gene amplification (6, 18) . However, the amplified sequences often appear to be unstable, and as a consequence, antibiotics are still needed to maintain the integrity of the amplified structures in the resulting strains. In our view, a system allowing the targeted integration of single copies of a heterologous gene at multiple locations in the bacterial genome without the simultaneous integration of markers (antibiotic resistance) would be highly preferable to the system indicated above and would provide genetically engineered strains that are more easily acceptable for production purposes. As reported in the present communication, we have devised such a system for the industrially important bacterium Bacillus subtilis.
It is well documented that folic acid antagonists like aminopterin and trimethoprim (TMP) prevent thymidylate biosynthesis in an indirect way by inhibition of dihydrofolate reductase, an essential enzyme in the synthesis of N 5 , N 10 -methylenetetrahydrofolate, which is the donor of the methyl group of thymidylate (35) . These compounds have been used to obtain thymine-requiring (thy) mutants in several genera of bacteria (22) . In B. subtilis, two mutations in the unlinked genes thyA and thyB encoding thymidylate synthetases (TSases), are required for thymine auxotrophy (Thy Ϫ ) (35) . The thyA gene of B. subtilis encodes the major TSase activity (21) . It was shown that thyA and thyA thyB mutants can incorporate exogenous thymine into DNA (35) . As a consequence, these mutants are resistant to folic acid analogs in the presence of thymine in the medium. In contrast, thyB mutants resemble the wild type in that they are unable to take up exogenous thymine. Both thyB and wild-type cells are sensitive to folic acid antagonists even when thymine is present in the medium (21, 35) . It has been observed that the thyP3 gene of the temperate B. subtilis bacteriophage 3T could transform B. subtilis thymine auxotrophs to prototrophy (Thy ϩ ). Furthermore, the resulting thymine-prototrophic strains appeared to be sensitive to TMP (Tmp s ) (26, 27) . We have used these observations to devise a strategy by which single copies of a heterologous gene can be integrated at different locations in the B. subtilis genome without the simultaneous integration of markers. The Bacillus stearothermophilus glgB gene, encoding glycogen branching enzyme (14) , was used as a model.
MATERIALS AND METHODS
Bacterial strains, plasmids, media, and biochemicals. The bacterial strains and plasmids used in this study are listed in Table 1 . TY broth and TY agar were prepared as described previously (2) . B. subtilis minimal medium consisted of Spizizen minimal salts medium (25) supplemented with glucose (0.5%), casein hydrolysate (0.02%), and the necessary amino acids and nucleotides (20 g/ml each). Antibiotics were added as required (Escherichia coli, ampicillin, 100 g/ ml; chloramphenicol, 10 g/ml; erythromycin, 100 g/ml; kanamycin, 50 g/ml; tetracycline, 10 g/ml; B. subtilis, erythromycin, 1 g/ml; kanamycin, 10 g/ml). TMP selection plates consisted of minimal medium solidified with 1.5% agar and supplemented with TMP (5 g/ml) and thymine.
Cultures of B. subtilis cells were made competent according to the method of Bron and Venema (4) . Competent E. coli cells were prepared by the CaCl 2 method as described previously (23) . Biochemicals were obtained from Boehringer (Mannheim, Germany) and were used according to the instructions of the supplier. Taq polymerase was obtained from Promega (Madison, Wis.). All other chemicals were analytical grade.
DNA procedures. Total genomic DNA was extracted from B. subtilis essentially as described previously (32) . Routine DNA manipulations, as described by Sambrook et al. (23) , were used throughout. Southern transfer was carried out by alkaline blotting of DNA restriction fragments on Qiabrane plus filters according to the protocol of the supplier (Qiagen Inc.). Probe labeling, setting up the hybridization conditions, and washing steps were performed according to the instructions of the manufacturers of the enhanced chemiluminescence gene detection system (Amersham International Plc., Amersham, United Kingdom). Labeled phage SPPI DNA was added to the hybridization mixtures to enable visualization of the marker. PCR-mediated DNA amplification was performed basically as described by Innes et al. (11) with a Bio-Med thermocycler 60 (B. Braun, Melsungen, Germany). Oligonucleotides were synthesized with an Applied Biosystems 381A DNA synthesizer (Applied Biosystems, Foster City, Calif.).
Protein analysis. Lysates of B. subtilis for use in sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting (immunoblotting) were prepared as follows. Cells were grown overnight at 37ЊC with vigorous shaking in B. subtilis minimal medium supplemented with the appropriate growth factors. The cultures were then diluted 100-fold in 100 ml of fresh medium and grown to an optical density at 600 nm of 0.4. Sucrose was then added to 2%, and the cells were cultured for an additional 4 h. Subsequently, the cells were pelleted by centrifugation, suspended in 2 ml of 25 mM sodium phosphate buffer (pH 7), and disrupted by the use of a French press. Cell debris was removed by centrifugation in an Eppendorf centrifuge. The protein content of the lysates was determined according to the method of Bradford (3). SDS-PAGE was performed according to the method of Laemmli (16) with a minigel system (Bio-Rad, Richmond, Calif.). Western blotting was performed essentially as described by Towbin et al. (29) . A prestained (rainbow) SDS-PAGE molecular mass standard (Amersham) was used as a reference.
Generation of polyclonal antibodies. The protein fusion and purification system supplied by New England Biolabs was used to purify a fusion protein expressed by an E. coli malE-B. stearothermophilus glgB fusion gene. To this effect, a BglII (blunted)-HindIII fragment of plasmid pKVS244/32-1 (unpublished data) specifying codons 8 to 639 of the B. stearothermophilus branching enzyme (14) was inserted in the StuI-HindIII-digested pMAL-C vector. Expression and purification of the fusion protein were performed according to the instructions of New England Biolabs. The fusion protein was further purified by electroelution from unstained SDS-polyacrylamide gels by the use of a Biotrap (Schleicher & Schuell, Dassel, Germany). Polyclonal antibodies specific for the fusion protein were raised in a rabbit.
Construction of plasmids. Plasmid pGKV11-thyP3 was constructed by the cloning of a 951-bp SspI fragment from plasmid pFT24 containing the coding region of the thyP3 gene of bacteriophage 3T (nucleotides [nt] 96 to 1056 in reference 13) in plasmid pGKV11 (partially digested with EcoRI and blunted by Klenow treatment). In pGKV11-thyP3, the thyP3 gene is under the control of the B. subtilis bacteriophage SPO2 promoter (34) .
pAMY4 was constructed as follows. First, two fragments of the B. subtilis amyE gene were cloned in plasmid pWSK29. These fragments were obtained via PCR. 
VOL. 61, 1995 INTEGRATION OF HETEROLOGOUS GENES IN BACILLUS SUBTILIS 4245
(i) A 0.6-kb XbaI-EcoRI fragment (nt 392 to 1036 of amyE [36] ) was obtained with oligonucleotide primers AMY3 (5Ј CAA AAT TCT AGA GTC TTC ACA TCG GTT TG) and AMY1 (5Ј GTT TTG AAT TCG TGT GTT TCC ATG TGT CCA G), and (ii) a 1.2-kb HindIII-XhoI fragment (nt 1463 to 2663 of amyE) was obtained with AMY2 (5Ј TGG ATA AGC TTT GAT GAT ATC CGT TTA GGC) and AMY4 (5Ј CAA ATG CAC TCG AGA TCA GCA TCC TTG CAG). Subsequently, the Em r gene from plasmid pUC18Em was inserted as an EcoRIHindIII fragment. Finally, the SPO2-thyP3 cassette from pGKV11-thyP3 was inserted as an EcoRI-SmaI fragment.
pNPR4 contains two fragments of the B. subtilis nprE gene. First, a 1.1-kb HpaI fragment containing the 3Ј end of nprE (nt 458 to 1596 in reference 37) was isolated from plasmid pGS1081, a derivative of plasmid pGS1 from which the EcoRI site in the nprE gene had been removed (7a) and then cloned in HindIIdigested pWSK29. Subsequently, a 0.9-kb BclI-HindIII (blunted) fragment of pGS1 containing the 5Ј end of nprE (up to nt 395 in reference 37) was cloned between the BamHI and SmaI sites of the resulting plasmid. Finally, the Em r and thyP3 genes were introduced as described for pAMY4. pGLG4 contains two fragments from the region of the B. subtilis chromosome carrying the trnB gene cluster and the glgBCDAP operon: (i) a 1.0-kb HindIIIApaI fragment from plasmid pKBU101 comprising part of the glgP gene (nt 6973 to 7985; EMBL accession number Z25795 [see reference 15] ), inserted between the HindIII and ApaI sites of pWSK29; and (ii) a 1.0-kb BglII-EcoRI fragment isolated from a subclone of plasmid pKBU1 carrying the NcoI-ScaI fragment of trnB (nt 6041 to 7063 in reference 9) between the NcoI and SmaI sites of the polylinker of pMTL23. In addition, pGLG4 contains the Em r and thyP3 genes, which were inserted as described for pAMY4.
Plasmids pAMY5, pNPR5, and pGLG5 are based on the plasmids pAMY4, pNPR4, and pGLG4, respectively. In these plasmids, the thyP3 and Em r genes have been replaced by an EcoRI-HindIII fragment from plasmid pKVS263 that carries the B. stearothermophilus glgB gene under the control of the inducible B. subtilis sacB promoter (unpublished data).
Plasmids pAMY4, pAMY5, pNPR4, pNPR5, pGLG4, and pGLG5 can only replicate in E. coli. Thus B. subtilis transformants can only be the result of integration of the plasmid or gene replacement between the plasmid and the chromosome. Our transformation protocol allowed the specific isolation of transformants resulting from gene replacement.
RESULTS

Development of the integration system.
Step 1: integration of the thyP3 gene. The principle behind the integration method is illustrated in Fig. 1 . As a first step in the development of the system, we placed the thyP3 gene from plasmid pFT24 under the control of the B. subtilis bacteriophage SPO2 promoter (see Materials and Methods). The resulting plasmid, pGKV11-thyP3, capable of replication in B. subtilis, transformed thymine-auxotrophic B. subtilis BD393 to prototrophy. In addition, the transformants were Tmp s .
For the strategy to function efficiently, integration of a single copy of the thyP3 cassette into the genome of B. subtilis BD393 should also result in a Thy ϩ Tmp s phenotype. In addition, because of the high level of similarity between the bacteriophage thyP3 gene and the B. subtilis thyA gene, recombination is expected to occur in a number of cases (26) (27) (28) . This should not interfere with the isolation of transformants carrying the thyP3 gene at the correct locus in the bacterial genome. To ascertain that these requirements could be met, we tested whether the plasmids pAMY4, pNPR4, and pGLG4 could target the thyP3 gene to the correct location in the genome of B. subtilis BD393. In pAMY4, pNPR4, and pGLG4, the thyP3 gene, joined to an Em r gene to evaluate the efficiency of the method, is flanked by parts of the B. subtilis amyE gene, parts of the nprE gene, and parts of the glycogen operon (trnBglgBCDAP region), respectively (see Materials and Methods). Transformants that arose from double crossover events between the plasmids and the bacterial chromosome were se- Table 2 shows that selection for thymine prototrophy yielded many transformants with pAMY4, pNPR4, and pGLG4, but that half of them were Em s , suggesting that recombination between the thyP3 gene and the mutant thyA gene had occurred rather frequently. In contrast, all Em r transformants appeared to be thymine prototrophic, although their number was rather low. Southern analysis of these transformants revealed that the thyP3 and Em r genes had indeed integrated at the desired locus (Fig. 2) . All of the Thy ϩ Em r transformants were sensitive to TMP, indicating that the presence of a single copy of the thyP3 cassette in the B. subtilis genome was sufficient to give the required phenotype. The resulting strains carrying the thyP3 and Em r genes at the amyE, 3) , and pGLG4 (lane 4); digested with HindIII; subjected to agarose gel electrophoresis; and blotted. Subsequently, the filter was hybridized successively to the following enhanced chemiluminescence-labeled probes: the amyE fragments of pAMY4 (A); the nprE fragments of pNPR4 (B); a 1.2-kb EcoRI fragment from pKBU1 carrying the 3Ј end of B. subtilis glgB and the 5Ј end of glgC (nt 1358 to 2538 in EMBL accession number Z25795 [15] ), which should be absent in pGLG4 transformants (C); and the thyP3 and Em r genes as present in pAMY4, pNPR4, and pGLG4 (D). Between reprobings, the filter was stripped by incubation for 30 min in 0.4 N NaOH. Fragment lengths of the marker (M), phage SPPI DNA restricted with EcoRI, are given in kilobases to the left. The faint hybridization signal in panel D represents the B. subtilis thyA gene, which hybridizes specifically to the thyP3 gene. (E) Genomic structure of the B. subtilis amyE, nprE, and glg loci before and after transformation with pAMY4, pNPR4, and pGLG4, respectively.
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nprE, and glg loci were designated BD393/A4, BD393/R4, and BD393/G4, respectively.
Step 2: integration of a heterologous gene. For the integration of a heterologous gene at the amyE, nprE, and glg loci, the mutant strains BD393/A4, BD393/R4, and BD393/G4 were transformed with the plasmids pAMY5, pNPR5, and pGLG5, respectively. In these plasmids, an expression cassette containing the B. stearothermophilus glgB gene under the control of the inducible B. subtilis sacB promoter is flanked by DNA fragments from the same chromosomal loci as those present in pAMY4, pNPR4, and pGLG4 (see Materials and Methods). Transformants that contain the heterologous glgB gene at the desired locus will have lost the thyP3 gene and therefore should be Tmp r . It appeared essential to decrease the considerable level of TSase activity present in the cells resulting from the expression of the thyP3 gene prior to its elimination by transformation. Therefore, the transformed cells were diluted in medium supplemented with thymine and incubated overnight at 37ЊC. Subsequently, transformants were isolated on TMP selection plates. Table 3 shows that this strategy was successful: after 48 h of growth, 2 to 8% of the Tmp r colonies were thymine auxotrophic as well as Em s , suggesting that they had lost both the thyP3 and Em r genes. The other Tmp r colonies remained thymine prototrophic and Em r . Southern hybridization revealed that almost invariably the Thy Ϫ Em s colonies carried the heterologous glgB gene at the desired position ( Table 3 ). The resulting strains, which carried one copy of the glgB cassette in the amyE gene, in the nprE gene, and in the glycogen operon, were designated BD393/A5, BD393/R5, and BD393/G5, respectively.
Integration of multiple copies of a heterologous gene in the B. subtilis chromosome. The strains carrying a single copy of the B. stearothermophilus glgB gene in their genomes have basically the same characteristics as the parent strain, BD393 (thymine auxotrophic and Tmp r ). In principle, these strains can be used directly for the integration of an additional copy of the glgB gene at a different locus by the same strategy. To demonstrate the feasibility of this approach, we transformed B. subtilis BD393/G5 with chromosomal DNA of strain BD393/R4 at low concentrations of DNA and selected thymine-prototrophic Em r transformants. Subsequently, one of these carrying the thyP3 and Em r genes at the nprE locus, designated BD393/ G5R4, was transformed with pNPR5. After allowing for segregational dilution of TSase activity, Tmp r thymine-auxotrophic colonies were isolated. This resulted in B. subtilis BD393/ G5R5, which carries single copies of the heterologous glgB gene at two different loci on its genome. In a similar way, a third copy of the glgB gene was integrated at the amyE locus in the chromosome of BD393/G5R5, resulting in strain BD393/ G5R5A5.
Production of B. stearothermophilus branching enzyme by B.
subtilis strains carrying the glgB cassette in multiple copies at various locations on the chromosome. To determine whether the increase in the copy number of the heterologous glgB gene in the chromosome of B. subtilis BD393 also enhanced enzyme production, we determined the amount of B. stearothermophilus branching enzyme synthesized by the various strains. In order to allow efficient transcription of the glgB cassette in all strains, the degU32(Hy) mutation was introduced, which is known to increase the levels of transcripts initiating at the sacB promoter without affecting sucrose inducibility (24) . Proteins in crude extracts of the mutant strains induced with sucrose were analyzed by Western blotting (Fig. 3) . This revealed that strains carrying a single copy of the glgB cassette in the amyE gene, in the glycogen operon, and in the nprE gene produced similar amounts of branching enzyme (compare lanes 1 to 3 in Fig. 3) . Furthermore, the increase in the number of copies of the integrated glgB cassette resulted in a cumulative increase in the amount of branching enzyme synthesized (Fig. 3, lanes 4  and 5) . We have also determined the production of branching enzyme by B. subtilis BD393[degU32(Hy)] (pKVS263), a strain carrying the glgB expression cassette on a plasmid. The production of branching enzyme by this system appeared to be comparable to that of BD393[degU32(Hy)]/A5R5, which carries two copies of the glgB cassette in its genome (compare lanes 4 and 6 in Fig. 3 ). Southern analysis revealed that under the circumstances employed here, the copy number of the plasmid was approximately 8 (Fig. 4) .
DISCUSSION
The present paper describes a strategy for integrating single copies of a heterologous gene at multiple locations in the chromosome of B. subtilis without the simultaneous integration of markers. This strategy can be a powerful tool for the construction of genetically engineered B. subtilis strains acceptable for production of clinically and industrially interesting enzymes. The devised method employs the high level of transformability of B. subtilis 168 strains. Unfortunately, industrial strains exhibiting natural competence are rare. However, we feel that any transformation protocol resulting in recombina- tion between the bacterial chromosome and the transformed DNA should make the strategy we propose a successful one.
We have used the well-characterized thyP3 gene to transform a thymine-auxotrophic B. subtilis mutant to prototrophy and, consequently, to make the cells Tmp s . The major drawback to the use of this gene in integration systems for B. subtilis is its high level of similarity to the B. subtilis thyA gene (28) , which is also demonstrated by the clear hybridization signal that we observed when the thyP3 gene was hybridized to B. subtilis BD393 DNA under stringent hybridization and washing conditions (Fig. 2D) . However, in this paper, we clearly show that the high level of similarity did not prevent integration of the thyP3 gene at the preferred locus with a high level of efficiency (Table 2) . Recently, the thyP22 gene from the B. subtilis bacteriophage ␤22 was sequenced and appeared to be only weakly similar to the B. subtilis thyA gene (1). This apparent lack of homology would make the thyP22 gene the ideal alternative to the thyP3 gene in the proposed integration system.
We have made use of an Em r marker in the development of the integration procedure. This allowed us to estimate the efficiency of integration of the thyP3 gene at the intended chromosomal locus. However, the antibiotic resistance gene is dispensable if thymine-prototrophic transformants obtained after the first round of transformation are screened directly by Southern analysis. Additionally, the antibiotic resistance marker is not essential in the second step of the strategy: Tmp r transformants that carry the heterologous gene can be isolated simply by being screened for thymine auxotrophy (Table 3 ). In some of the examples described here, the initial integrations resulted in the disruption of a gene conferring an easily observable phenotype (e.g., screening in a plate assay for ␣-amylase-negative transformants in the case of integration in the amyE gene with plasmid pAMY4). However, we have dispensed with screening for such phenotypes, since we wanted to develop a strategy that would be generally applicable.
The level of efficiency of the integration method described in this paper seems to be rather low. Only approximately 5% of the Tmp r colonies obtained after transformation with plasmids carrying the heterologous gene appeared to be of the desired type (Table 3) . Apparently, the remainder of the Tmp r colonies still carried the thyP3 and Em r genes in their genomes. We have observed that Tmp r colonies also arose when competent cells of B. subtilis BD393 mutants carrying the thyP3 gene were plated on TMP selection medium without transformation. This suggests that spontaneous mutations resulting in Tmp r occur rather frequently in B. subtilis. Usually, cells become Tmp r when the enzyme dihydrofolate reductase, which is essential for the synthesis of the precursor of the methyl group of thymidylate, is overproduced or is no longer inhibited by TMP (20) . However, the appearance of these spontaneous Tmp r mutants will not affect the isolation of mutants carrying the heterologous gene, because true transformants can be simply isolated by being screened for thymine auxotrophy.
The strategy that is presented here has exclusively been used to integrate multiple copies of a heterologous gene in the B. subtilis genome. However, the two-step transformation procedure can also be of advantage to other systems that involve an exchange between the chromosome of B. subtilis and extrachromosomal DNA. For example, the strategy can be adapted to allow construction of ''clean'' deletion mutants of B. subtilis, strains that do not carry integrated (antibiotic resistance) markers. In this case, mutant strains that have integrated the thyP3 gene at the desired locus are transformed with a plasmid carrying the intended deletion. Another adaptation of the strategy presented here would be the replacement of wild-type genes by genes mutated in vitro, resulting in strains carrying exclusively the intended mutation at the original locus on the B. subtilis chromosome.
The B. subtilis derivatives constructed in the present study carried one or several chromosomally located copies of a cassette containing the B. stearothermophilus glgB gene under the control of the B. subtilis sacB promoter. In the past, Kallio et al. (12) showed that randomly integrated copies of the Bacillus amyloliquefaciens ␣-amylase gene in the chromosome of B. subtilis produced significantly larger amounts of ␣-amylase than copies located on a derivative of the multicopy Staphylococcus aureus plasmid pUB110, which is segregationally unstable in B. subtilis. Our data seem to confirm these results: a B. subtilis strain carrying two copies of the glgB cassette in its chromosome already produced amounts of branching enzyme equal to those produced by a system in which the cassette was carried on a segregationally rather stable, low-copy-number plasmid (Fig. 4) .
